Streetbeat News

Stock Prices

DOCS

Doximity has issued Q2 and FY23 revenue guidance below estimates, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:49 pm

NVEI

Nuvei reported mixed Q2 financial results and issued Q3 revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:48 pm

PUBM

PubMatic, Inc. (NASDAQ:PUBM) reported better-than-expected Q2 sales but issued a weak revenue forecast for Q3. The company's Q2 sales were $63.33 million, beating estimates of $59.89 million. However, its Q3 revenue forecast of $58 million to $61 million fell short of expectations of $65.93 million. Following the announcement, PubMatic's shares dipped 19% and analysts from Raymond James, Macquarie, and Oppenheimer revised their price targets and ratings.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 12:46 pm

CELH

PEP

Celsius Holdings Inc (NASDAQ:CELH) reported better-than-expected Q2 financial results, with revenues of $326 million and EPS of 52 cents, beating estimates. The company's total revenue was up 112% YoY, with international revenue increasing by 76% and North America revenue up by 114%. The company attributed its strong growth to gains in distribution points, increased SKUs per location, Club Channel growth, and increased sales and marketing investments. Celsius also leveraged PepsiCo Inc's (NASDAQ:PEP) distribution system. The company ended the quarter with $681 million in cash and equivalents.

Portfolio Pulse from Adam Eckert

August 09, 2023 | 12:46 pm

EBIX

Ebix reported Q2 earnings of $0.23 per share, missing the analyst consensus estimate of $0.24 by 4.17%. The company's quarterly sales were $118.43 million, missing the analyst consensus estimate of $197.88 million by 40.15%. This represents a 69.33% decrease in earnings and a 52.78% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:45 pm

AVNS

Trading of Avanos Medical shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:43 pm

TTOO

T2 Biosystems, Inc. (NASDAQ:TTOO) has regained compliance with the NASDAQ's market value of listed securities (MVLS) requirement. The company was previously notified of non-compliance due to failure to maintain a MVLS of at least $35 million for 30 consecutive business days. To regain compliance, T2 Biosystems maintained a MVLS of at least $35 million for 10 consecutive trading days. The company must still demonstrate compliance with the Bid Price Rule by November 20, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:39 pm

CB

CVS

JEPQ

MS

On CNBC's 'Halftime Report Final Trades', several financial experts gave their opinions on various stocks and ETFs. Bryn Talkington recommended JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) due to its 10% distribution yield. Josh Brown suggested Chubb Limited (CB) following its better-than-expected Q2 results. Sarat Sethi defended Morgan Stanley (MS) which was beaten down on Tuesday, despite its strong Q2 results. Stephanie Link recommended CVS Health Corporation (CVS) which she considers undervalued and highlighted its Q2 sales increase of 10.3% YoY.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 12:38 pm

WE

BTIG analyst Thomas Catherwood has downgraded WeWork (NYSE:WE) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 12:36 pm

PUBM

Macquarie analyst Tim Nollen has downgraded PubMatic (NASDAQ:PUBM) from Outperform to Neutral and lowered the price target from $23 to $16.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 12:35 pm